Breakthrough in Malaria detection: new FREM platform delivers 98% accuracy for rapid screening and genotyping Post author: Post published:December 1, 2023 Post category:uncategorized The Flexible, Robust, Equipment-free Microfluidic (FREM) platform for malaria screening and Plasmodium species genotyping. You Might Also Like Micropore appoints new CEO August 30, 2024 Exploring alemtuzumab in reduced-toxicity conditioning for Asian patients with inborn errors of immunity July 28, 2024 New automated system revolutionizes drug evaluation in zebrafish March 11, 2025
Exploring alemtuzumab in reduced-toxicity conditioning for Asian patients with inborn errors of immunity July 28, 2024